Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products

Published - Aug 2011| Analyst - Peggy Lehr| Code - HLC092A
Market Research Report Single User License: $2,750 Member Price: FREE

Report Highlights

The global market for healthcare-acquired infection treatments were nearly $16 billion in year 2010. This market is estimated to be around $18.3 billion in the year 2011 and is forecasted to reach $25.6 billion by 2016 at a CAGR of 7.0% for five year period.

STUDY GOALS AND OBJECTIVES

Healthcare-acquired infections are viral, bacterial, or fungal infections that patients acquire after they are admitted to a healthcare facility.  Patients can acquire these infections from routine care; surgery; or as a complication from the use of medical devices such as ventilators, catheters, and intravenous lines. 

The Centers for Disease Control (CDC) estimates that 2 million HAIs occur annually in the U.S.  This leads to 100,000 deaths and costs an additional $36 billion to $45 billion in direct medical costs annually. 

This report is designed to investigate the global HAI market by treatment area and by treatment type, with supporting tables and figures to illustrate projected growth.  The report will include the U.S., Europe, Japan, and other countries such as China. 

This report offers forecasts of the markets for devices, pharmaceuticals, and therapies by treatment segment and treatment type from 2011 through 2016, including supporting analyses for projections.

This report is a valuable tool for anyone assessing the HAI market and attempting to devise a strategy to successfully compete in this market.  It provides background on the structure of the HAI market and the chief challenges and opportunities it faces.  It offers the information needed to understand the current market and to address the emerging one. 

This is an invaluable tool for business planners; acquisition specialists; licensing strategists; product managers; market research analysts; investing consultants; and others interested in the HAI market, its products, its participants, and its future.

ANALYST CREDENTIALS

Peggy S. Lehr is the BCC Research analyst of this report.  Ms. Lehr holds a BS in Journalism from the University of Colorado, Boulder and an MS in Communication from the University of Denver.  Ms. Lehr has worked in the publishing industry with both for-profit and not-for-profit organizations.  She specializes in marketing reports on the medical industry. 

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
RELATED REPORTS
Share This Report